Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24 Week Randomised Double Blind Placebo Controlled Study to Evaluate the Atrophogenic Potential of Eflornithine in the Treatment of Women With Excessive Facial Hair

NCT00152048 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00152048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00152048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24 Week Randomised Double Blind Placebo Controlled Study to Evaluate the Atrophogenic Potential of Eflornithine in the Treatment of Women With Excessive Facial Hair
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2004
Completion date
October 31, 2005
Enrollment
78
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hirsutism